C-Section bleeding breakthrough? new study tests simple topical drug

NCT ID NCT07362992

Recruiting now Disease control Sponsor: Wolfson Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests whether putting tranexamic acid (a drug that helps blood clot) directly on the womb during a planned C-section can reduce bleeding during surgery. About 112 women having their first or second C-section will be randomly assigned to receive either the drug or a placebo. The main goals are to see if it shortens the time to close the womb and reduces the need for extra stitches to stop bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CESAREAN DELIVERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Blood Loss, Surgical Postpartum Hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CESAREAN DELIVERY HEMOSTASIS INTRAOPERATIVE BLOOD LOSS POSTPARTUM HEMORRHAGE (PPH)

Contacts and locations

Locations

Edith Wolfson Medical Center
RECRUITING

Holon, Central District, 5834468, Israel
Kaplan medical center
NOT_YET_RECRUITING

Rehovot, Israel
Meir medical center
NOT_YET_RECRUITING

Kfar Saba, Israel
Rabin medical center
NOT_YET_RECRUITING

Petah Tikva, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.